Search Results - "Doench, John"

Refine Results
  1. 1

    Am I ready for CRISPR? A user's guide to genetic screens by Doench, John G.

    Published in Nature reviews. Genetics (01-02-2018)
    “…Key Points Pooled screens are a cost-effective approach to investigating phenotypes at the genome scale and build on technological innovations with lentivirus,…”
    Get full text
    Journal Article
  2. 2

    Design and analysis of CRISPR–Cas experiments by Hanna, Ruth E., Doench, John G.

    Published in Nature biotechnology (01-07-2020)
    “…A large and ever-expanding set of CRISPR–Cas systems now enables the rapid and flexible manipulation of genomes in both targeted and large-scale experiments…”
    Get full text
    Journal Article
  3. 3

    CRISPR screens for functional interrogation of immunity by Shi, Hao, Doench, John G., Chi, Hongbo

    Published in Nature reviews. Immunology (01-06-2023)
    “…CRISPR-based technologies represent a major breakthrough in biomedical science as they offer a powerful platform for unbiased screening and functional genomics…”
    Get full text
    Journal Article
  4. 4

    Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation by Doench, John G, Hartenian, Ella, Graham, Daniel B, Tothova, Zuzana, Hegde, Mudra, Smith, Ian, Sullender, Meagan, Ebert, Benjamin L, Xavier, Ramnik J, Root, David E

    Published in Nature biotechnology (01-12-2014)
    “…Analysis of the genome editing activity of more than 1800 sgRNAs in mouse and human cells yields rules to facilitate design of highly active RNA guides for…”
    Get full text
    Journal Article
  5. 5

    Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities by Sanson, Kendall R., Hanna, Ruth E., Hegde, Mudra, Donovan, Katherine F., Strand, Christine, Sullender, Meagan E., Vaimberg, Emma W., Goodale, Amy, Root, David E., Piccioni, Federica, Doench, John G.

    Published in Nature communications (21-12-2018)
    “…The creation of genome-wide libraries for CRISPR knockout (CRISPRko), interference (CRISPRi), and activation (CRISPRa) has enabled the systematic interrogation…”
    Get full text
    Journal Article
  6. 6

    Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map by Smith, Ian, Greenside, Peyton G, Natoli, Ted, Lahr, David L, Wadden, David, Tirosh, Itay, Narayan, Rajiv, Root, David E, Golub, Todd R, Subramanian, Aravind, Doench, John G

    Published in PLoS biology (30-11-2017)
    “…The application of RNA interference (RNAi) to mammalian cells has provided the means to perform phenotypic screens to determine the functions of genes…”
    Get full text
    Journal Article
  7. 7

    Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway by Evavold, Charles L., Hafner-Bratkovič, Iva, Devant, Pascal, D’Andrea, Jasmin M., Ngwa, Elsy M., Boršić, Elvira, Doench, John G., LaFleur, Martin W., Sharpe, Arlene H., Thiagarajah, Jay R., Kagan, Jonathan C.

    Published in Cell (19-08-2021)
    “…The process of pyroptosis is mediated by inflammasomes and a downstream effector known as gasdermin D (GSDMD). Upon cleavage by inflammasome-associated…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells by Shalem, Ophir, Sanjana, Neville E., Hartenian, Ella, Shi, Xi, Scott, David A., Mikkelsen, Tarjei S., Heckl, Dirk, Ebert, Benjamin L., Root, David E., Doench, John G., Zhang, Feng

    “…The simplicity of programming the CRISPR (clustered regularly interspaced short palindromic repeats)–associated nuclease Cas9 to modify specific genomic loci…”
    Get full text
    Journal Article
  11. 11

    Genetic screens and functional genomics using CRISPR/Cas9 technology by Hartenian, Ella, Doench, John G

    Published in The FEBS journal (01-04-2015)
    “…Functional genomics attempts to understand the genome by perturbing the flow of information from DNA to RNA to protein, in order to learn how gene dysfunction…”
    Get full text
    Journal Article
  12. 12

    Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis by Zou, Yilong, Li, Haoxin, Graham, Emily T., Deik, Amy A., Eaton, John K., Wang, Wenyu, Sandoval-Gomez, Gerardo, Clish, Clary B., Doench, John G., Schreiber, Stuart L.

    Published in Nature chemical biology (01-03-2020)
    “…Ferroptosis is widely involved in degenerative diseases in various tissues including kidney, liver and brain, and is a targetable vulnerability in multiple…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin by Wijshake, Tobias, Zou, Zhongju, Chen, Beibei, Zhong, Lin, Xiao, Guanghua, Xie, Yang, Doench, John G., Bennett, Lynda, Levine, Beth

    “…Beclin 1, an autophagy and haploinsufficient tumor-suppressor protein, is frequently monoallelically deleted in breast and ovarian cancers. However, the…”
    Get full text
    Journal Article
  15. 15

    A Genome-wide CRISPR Death Screen Identifies Genes Essential for Oxidative Phosphorylation by Arroyo, Jason D., Jourdain, Alexis A., Calvo, Sarah E., Ballarano, Carmine A., Doench, John G., Root, David E., Mootha, Vamsi K.

    Published in Cell metabolism (13-12-2016)
    “…Oxidative phosphorylation (OXPHOS) is the major pathway for ATP production in humans. Deficiencies in OXPHOS can arise from mutations in either mitochondrial…”
    Get full text
    Journal Article
  16. 16

    Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 by Doench, John G, Fusi, Nicolo, Sullender, Meagan, Hegde, Mudra, Vaimberg, Emma W, Donovan, Katherine F, Smith, Ian, Tothova, Zuzana, Wilen, Craig, Orchard, Robert, Virgin, Herbert W, Listgarten, Jennifer, Root, David E

    Published in Nature biotechnology (01-02-2016)
    “…Genome-wide sgRNA libraries based on rules for on-target activity improve results of Cas9-based screens and facilitate a further refinement of on- and…”
    Get full text
    Journal Article
  17. 17

    Cas9 activates the p53 pathway and selects for p53-inactivating mutations by Enache, Oana M., Rendo, Veronica, Abdusamad, Mai, Lam, Daniel, Davison, Desiree, Pal, Sangita, Currimjee, Naomi, Hess, Julian, Pantel, Sasha, Nag, Anwesha, Thorner, Aaron R., Doench, John G., Vazquez, Francisca, Beroukhim, Rameen, Golub, Todd R., Ben-David, Uri

    Published in Nature genetics (01-07-2020)
    “…Cas9 is commonly introduced into cell lines to enable CRISPR–Cas9-mediated genome editing. Here, we studied the genetic and transcriptional consequences of…”
    Get full text
    Journal Article
  18. 18

    Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy by Wei, Jun, Long, Lingyun, Zheng, Wenting, Dhungana, Yogesh, Lim, Seon Ah, Guy, Cliff, Wang, Yanyan, Wang, Yong-Dong, Qian, Chenxi, Xu, Beisi, KC, Anil, Saravia, Jordy, Huang, Hongling, Yu, Jiyang, Doench, John G., Geiger, Terrence L., Chi, Hongbo

    Published in Nature (London) (01-12-2019)
    “…Adoptive cell therapy represents a new paradigm in cancer immunotherapy, but it can be limited by the poor persistence and function of transferred T cells 1 …”
    Get full text
    Journal Article
  19. 19
  20. 20

    Defective NADPH production in mitochondrial disease complex I causes inflammation and cell death by Balsa, Eduardo, Perry, Elizabeth A., Bennett, Christopher F., Jedrychowski, Mark, Gygi, Steven P., Doench, John G., Puigserver, Pere

    Published in Nature communications (01-06-2020)
    “…Electron transport chain (ETC) defects occurring from mitochondrial disease mutations compromise ATP synthesis and render cells vulnerable to nutrient and…”
    Get full text
    Journal Article